Figures & data
Figure 1 (A) FA and (B) ICGA studies of patient 1 prior to treatment with combination PDT and bevacizumab demonstrating (A) late focal leakage in the papillomacular bundle as well as focal staining and a PED and (B) ICGA showing increased choroidal perfusion and probable focal PED. No definitive CNV was identified.
![Figure 1 (A) FA and (B) ICGA studies of patient 1 prior to treatment with combination PDT and bevacizumab demonstrating (A) late focal leakage in the papillomacular bundle as well as focal staining and a PED and (B) ICGA showing increased choroidal perfusion and probable focal PED. No definitive CNV was identified.](/cms/asset/aa61b8d7-7771-4d7b-9720-b0585a1fe55f/doph_a_135461_f0001_b.jpg)
Table 1 Principal clinical characteristics of eight eyes of eight patients included in the report
Figure 2 OCT studies and macular thickness of patient 7.
Abbreviations: OCT, optical coherence tomography; PDT, photodynamic therapy.
![Figure 2 OCT studies and macular thickness of patient 7.](/cms/asset/e880a923-4c98-488c-96d8-d2327a8435b8/doph_a_135461_f0002_c.jpg)